Dutch Economic Value of Radium-223 in Metastatic Castration-Resistant Prostate Cancer
BACKGROUND: The treatment of metastatic castration-resistant prostate cancer has changed with the introduction of radium-223, cabazitaxel, abiraterone and enzalutamide. To assess value for money, their cost effectiveness in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel from the Dutch societal perspective was investigated. METHODS: A cost-effectiveness analysis was conducted using efficacy, symptomatic skeletal-related event and safety data obtained from indirect treatment comparisons. Missing skeletal-related event data for cabazitaxel were con... Mehr ...
| Verfasser: | |
|---|---|
| Dokumenttyp: | Artikel |
| Erscheinungsdatum: | 2018 |
| Reihe/Periodikum: | Peters , ML , De Meijer , C , Wyndaele , D , Noordzij , W , Leliveld , A M , van den Bosch , J , Van den Berg , PH , Baka , A & Gaultney , J 2018 , ' Dutch Economic Value of Radium-223 in Metastatic Castration-Resistant Prostate Cancer ' , Applied Health Economics and Health Policy , vol. 16 , no. 1 , pp. 133-143 . https://doi.org/10.1007/s40258-017-0350-x |
| Schlagwörter: | COST-EFFECTIVENESS ANALYSIS / QUALITY-OF-LIFE / ABIRATERONE ACETATE / BONE METASTASES / DOCETAXEL TREATMENT / RANDOMIZED-TRIAL / UTILITY ANALYSIS / DOUBLE-BLIND / ENZALUTAMIDE / CHEMOTHERAPY |
| Sprache: | Englisch |
| Permalink: | https://search.fid-benelux.de/Record/base-29028577 |
| Datenquelle: | BASE; Originalkatalog |
| Powered By: | BASE |
| Link(s) : | https://hdl.handle.net/11370/b3b78a6a-cdc7-468d-ae1d-599e53fa6dac |
